Additionally, the tumor cells were positive for Gata3, a marker supporting the diagnosis of a primary breast carcinoma origin. In summary, the patient’s final diagnosis was synchronous cervical carcinoma stage II B and right breast cancer that is HER2-negative, ER-negative, and PgR-negative T1b N1M 0. This evidence concerns the gene ERBB2 and breast carcinoma.